vs
Laird Superfood, Inc.（LSF）与礼来（RNA）财务数据对比。点击上方公司名可切换其他公司
Laird Superfood, Inc.的季度营收约是礼来的1.1倍（$13.3M vs $12.5M），Laird Superfood, Inc.净利率更高（-13.2% vs -1398.3%，领先1385.2%），礼来同比增速更快（434.0% vs 15.0%），过去两年礼来的营收复合增速更高（138.5% vs 16.1%）
Laird Superfood是一家主营植物基功能性超级食品的企业，产品涵盖精品咖啡奶精、补水混合饮品、营养补充剂、植物能量零食等，面向健康意识较强的消费群体，主要在北美市场通过电商及线下零售渠道销售，主打可持续采购的清洁配方。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
LSF vs RNA — 直观对比
营收规模更大
LSF
是对方的1.1倍
$12.5M
营收增速更快
RNA
高出419.0%
15.0%
净利率更高
LSF
高出1385.2%
-1398.3%
两年增速更快
RNA
近两年复合增速
16.1%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.3M | $12.5M |
| 净利润 | $-1.8M | $-174.4M |
| 毛利率 | 34.1% | — |
| 营业利润率 | -13.5% | -1513.5% |
| 净利率 | -13.2% | -1398.3% |
| 营收同比 | 15.0% | 434.0% |
| 净利润同比 | -341.4% | -117.0% |
| 每股收益（稀释后） | — | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LSFRNA
| Q4 25 | $13.3M | — | ||
| Q3 25 | $12.9M | $12.5M | ||
| Q2 25 | $12.0M | $3.8M | ||
| Q1 25 | $11.7M | $1.6M | ||
| Q4 24 | $11.6M | $3.0M | ||
| Q3 24 | $11.8M | $2.3M | ||
| Q2 24 | $10.0M | $2.0M | ||
| Q1 24 | $9.9M | $3.5M |
净利润LSFRNA
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-975.1K | $-174.4M | ||
| Q2 25 | $-362.2K | $-157.3M | ||
| Q1 25 | $-156.2K | $-115.8M | ||
| Q4 24 | $-398.4K | $-102.3M | ||
| Q3 24 | $-166.1K | $-80.4M | ||
| Q2 24 | $-239.1K | $-70.8M | ||
| Q1 24 | $-1.0M | $-68.9M |
毛利率LSFRNA
| Q4 25 | 34.1% | — | ||
| Q3 25 | 36.5% | — | ||
| Q2 25 | 39.9% | — | ||
| Q1 25 | 41.9% | — | ||
| Q4 24 | 38.6% | — | ||
| Q3 24 | 43.0% | — | ||
| Q2 24 | 41.8% | — | ||
| Q1 24 | 40.0% | — |
营业利润率LSFRNA
| Q4 25 | -13.5% | — | ||
| Q3 25 | -7.7% | -1513.5% | ||
| Q2 25 | -3.3% | -4448.7% | ||
| Q1 25 | -1.9% | -8360.9% | ||
| Q4 24 | -4.1% | -4069.6% | ||
| Q3 24 | -2.3% | -4200.9% | ||
| Q2 24 | -3.4% | -4040.4% | ||
| Q1 24 | -11.0% | -2178.6% |
净利率LSFRNA
| Q4 25 | -13.2% | — | ||
| Q3 25 | -7.6% | -1398.3% | ||
| Q2 25 | -3.0% | -4089.3% | ||
| Q1 25 | -1.3% | -7360.0% | ||
| Q4 24 | -3.4% | -3439.5% | ||
| Q3 24 | -1.4% | -3441.7% | ||
| Q2 24 | -2.4% | -3461.8% | ||
| Q1 24 | -10.3% | -1943.4% |
每股收益（稀释后）LSFRNA
| Q4 25 | — | — | ||
| Q3 25 | — | $-1.27 | ||
| Q2 25 | — | $-1.21 | ||
| Q1 25 | — | $-0.90 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | — | $-0.65 | ||
| Q2 24 | — | $-0.65 | ||
| Q1 24 | — | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.1M | $350.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $11.5M | $1.9B |
| 总资产 | $19.2M | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LSFRNA
| Q4 25 | $5.1M | — | ||
| Q3 25 | $5.1M | $350.2M | ||
| Q2 25 | $3.9M | $243.9M | ||
| Q1 25 | $7.0M | $254.2M | ||
| Q4 24 | $8.3M | $219.9M | ||
| Q3 24 | $7.9M | $370.2M | ||
| Q2 24 | $7.6M | $575.8M | ||
| Q1 24 | $7.1M | $471.4M |
股东权益LSFRNA
| Q4 25 | $11.5M | — | ||
| Q3 25 | $12.8M | $1.9B | ||
| Q2 25 | $13.4M | $1.2B | ||
| Q1 25 | $13.3M | $1.3B | ||
| Q4 24 | $13.2M | $1.4B | ||
| Q3 24 | $13.1M | $1.5B | ||
| Q2 24 | $12.6M | $1.2B | ||
| Q1 24 | $12.7M | $830.9M |
总资产LSFRNA
| Q4 25 | $19.2M | — | ||
| Q3 25 | $18.9M | $2.1B | ||
| Q2 25 | $20.4M | $1.4B | ||
| Q1 25 | $21.5M | $1.5B | ||
| Q4 24 | $19.3M | $1.6B | ||
| Q3 24 | $18.8M | $1.6B | ||
| Q2 24 | $18.0M | $1.3B | ||
| Q1 24 | $17.6M | $951.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $68.4K | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-156.9M |
| 自由现金流率自由现金流/营收 | — | -1257.6% |
| 资本支出强度资本支出/营收 | — | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-592.3M |
8季度趋势，按日历期对齐
经营现金流LSFRNA
| Q4 25 | $68.4K | — | ||
| Q3 25 | $1.2M | $-156.2M | ||
| Q2 25 | $-2.8M | $-199.7M | ||
| Q1 25 | $-1.3M | $-124.8M | ||
| Q4 24 | $339.2K | $-99.9M | ||
| Q3 24 | $305.8K | $-65.6M | ||
| Q2 24 | $642.7K | $-65.0M | ||
| Q1 24 | $-422.3K | $-70.4M |
自由现金流LSFRNA
| Q4 25 | — | — | ||
| Q3 25 | — | $-156.9M | ||
| Q2 25 | — | $-203.0M | ||
| Q1 25 | — | $-128.6M | ||
| Q4 24 | — | $-103.8M | ||
| Q3 24 | — | $-67.3M | ||
| Q2 24 | — | $-65.5M | ||
| Q1 24 | — | $-71.3M |
自由现金流率LSFRNA
| Q4 25 | — | — | ||
| Q3 25 | — | -1257.6% | ||
| Q2 25 | — | -5277.1% | ||
| Q1 25 | — | -8174.3% | ||
| Q4 24 | — | -3491.0% | ||
| Q3 24 | — | -2881.8% | ||
| Q2 24 | — | -3204.6% | ||
| Q1 24 | — | -2012.3% |
资本支出强度LSFRNA
| Q4 25 | — | — | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | 86.9% | ||
| Q1 25 | — | 238.6% | ||
| Q4 24 | — | 131.7% | ||
| Q3 24 | — | 72.9% | ||
| Q2 24 | — | 26.0% | ||
| Q1 24 | — | 25.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
RNA
暂无分部数据
